From Emerging Markets, For Emerging Markets

---

KPIs:

• Product Pipeline Strength: Number of products in the biotech’s pipeline.
• Origin Country Approvals: Number of products registered in the biotech’s country of origin.
• International Registrations: Number of products registered outside the country of origin.
• Compliance with Standards: Successful PICS or SRA inspection pass rates.
• Affordability: Competitive pricing of products in target markets.
• Product Quality: Adherence to global manufacturing and performance standards.
• Dossier Quality: Completeness and accuracy of regulatory dossiers.
• Clinical Data Robustness: Depth and quality of clinical data submitted.

KPIs:

• Sales Forecast Accuracy: Alignment between predicted and actual sales volumes.
• Payment Term Capacity: Ability to handle flexible payment terms effectively.
• Local Know-How: Depth of understanding of the local market landscape.
• Regional Reach: Coverage across multiple geographies or ability to expand into adjacent territories.
• Regulatory and Sales Team Strength: Capacity and expertise to register and sell products.
• Registration Speed: Time taken to complete product registration in target markets.

KPIs:

• Capacity Utilization: Percentage of manufacturing capacity consistently used.
• On-Time Delivery: Adherence to production and delivery schedules.
• Regulatory Compliance: Audit success rates and alignment with GMP and international standards.
• Production Scalability: Ability to ramp up production volumes.
• Government Relationships: Strength of connections with government agencies for localization support.
• Tender Negotiation Ability: Effectiveness in securing tenders through localization strategies.